Gilad Mamlok
Chief Financial Officer, Protalix Biotherapeutics Inc.
Companies
- Ellomay Capital LtdBoard member Mar 18, 2026 to now1
- Protalix Biotherapeutics IncChief financial officer Aug 25, 2025 to now2
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Protalix Biotherapeutics Inc PLX3,631 shares3$9.9K at $2.71Apr 27, 2026
As of each latest filing. The line shows shares held over time.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGAREllomay Capital Ltd, Board member
- 2
- 3